Assessing Neutrophil CD64 Expression: A Key Biomarker for Diagnosing Infections and Evaluating Antibiotic Therapy in Acute Leukemia Patients

Iranian Journal of Blood and Cancer · Published 2024-09-01 · DOI 10.61186/ijbc.16.3.23

Authors being retrieved — see the publisher record. https://doi.org/10.61186/ijbc.16.3.23

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• F8 Gene Splice Donor Mutation (c.1271+1G>A) in Individual with Mild Hemophilia A in Indonesia: A Case Study · Iranian Journal of Blood and Cancer · 2024 · Same journal
• Evaluation of the Home Safety and Child-friendly Environment for Children with Bleeding Tendency Disorders · Iranian Journal of Blood and Cancer · 2024 · Same journal
• Application of Artificial Intelligence in Celiac Disease: from diagnosis to patient follow-up · Iranian Journal of Blood and Cancer · 2023 · Same journal
• Molecular Pathways of Gliomas Involving RNA-Binding Protein Dynamics · Iranian Journal of Blood and Cancer · 2024 · Same journal
• Remodeling Methods of TIME for Enhanced Immunotherapy against Non-Melanoma Skin Cancer · Iranian Journal of Blood and Cancer · 2023 · Same journal
• Categorized Serum miRNAs as Potential Biomarkers for Predicting the Progression and Prognosis of Colorectal Cancer · Iranian Journal of Blood and Cancer · 2024 · Same journal
• Flow Cytometry-based Functional Assay is a Valuable Diagnostic Approach for Confirmation of Heparin-Induced Thrombocytopenia · Iranian Journal of Blood and Cancer · 2024 · Same journal
• Artificial intelligence (AI): The next stage of evolution? · Iranian Journal of Blood and Cancer · 2023 · Same journal
• Guideline for the diagnosis and treatment of diabetes mellitus in patients with transfusion-dependent thalassemia · Iranian Journal of Blood and Cancer · 2023 · Same journal
• Analysis of Coagulation Parameters in Patients with Breast Pathology and Their Possible Relevance to a Hypercoagulable State · Iranian Journal of Blood and Cancer · 2024 · Same journal